kevin sayer: Live & Latest News Updates : Vimarsana.com

DexCom (DXCM) Q1 2024 Earnings Call Transcript

DXCM earnings call for the period ending March 31, 2024.

Dexcom Stock Surged On An FDA Ruling. Continuous Glucose Monitors Aren't Just For Diabetics Now.

Dexcom Publishes Annual Sustainability Report

Report advances Dexcom’s corporate sustainability disclosures, including expanded greenhouse gas emissions data and greater transparency in pay-equity practices ...

DexCom (DXCM) Q4 2023 Earnings Call Transcript

DXCM earnings call for the period ending December 31, 2023.

DexCom, Inc. (NASDAQ:DXCM) Q4 2023 Earnings Call Transcript

DexCom, Inc. (NASDAQ:DXCM) Q4 2023 Earnings Call Transcript February 8, 2024 DexCom, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to the Dexcom Fourth Quarter and Fiscal Year 2023 Earnings Conference Call. My name is […]

Continuous Glucose Monitor Maker Dexcom's Q4 Profit Triples On Volume Growth And New Customer Additions - DexCom (NASDAQ:DXCM)

Dexcom's Q4 2023 performance, reporting $1.03 billion sales, $256.3 million profits, and beating estimates. Dexcom projects $4.15-$4.35 billion in 2024 revenues. William Blair affirms Outperform rating.

Prediction: 2 Stocks That Could Trounce the Market

They have done it before.

Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Dexcom launches new ONE+ CGM system in Europe

Dexcom (Nasdaq:DXCM) announced today that it launched its latest continuous glucose monitor (CGM) system, the Dexcom ONE+.

Diabetes Archives